Gudrun Lange

Source: LinkedIn

Gudrun Lange, PhD, is a clinical neuropsychologist who works with Dr. Benjamin Natelson at the Pain & Fatigue Study Center, New York, New York. There she heads studies on brain fog in chronic fatigue syndrome and fibromyalgia.

Committees and Boards

• Dec 2017 - Dec 2021, a voting member of the Chronic Fatigue Syndrome Advisory Committee for the U.S. Department of Health and Human Services

• 2017-2018, Chair of the CNS Imaging subgroup of the Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.

Notable studies

• 2001, Health-Related Personality Variables in Chronic Fatigue Syndrome and Multiple Sclerosis (Abstract)
• 2002, A status report on chronic fatigue syndrome (Full Text)
• 2004, Cognitive Function Index for Patients with Chronic Fatigue Syndrome
• 2005, Objective evidence of cognitive complaints in Chronic Fatigue Syndrome: a BOLD fMRI study of verbal working memory (Abstract)
• 2013, Attention network test: assessment of cognitive function in chronic fatigue syndrome
• 2011, Safety and efficacy of vagus nerve stimulation in fibromyalgia: a phase I/II proof of concept trial
• 2015, Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial(Full Text)
• 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study (Full Text)
• 2017, Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity (Full Text)
• 2019, The effect of comorbid medical and psychiatric diagnoses on chronic fatigue syndrome - (Full text)

Talks and interviews

• 2009, 9th International IACFS/ME Research and Clinical Conference: Talk Title - Assessing ME/CFS Brain Functioning
• 11 April 2012, "Cognition & CFS: What Do We Know?" by the CFIDS Association of America with speakers Gudren Lange and Suzanne Vernon, introduced by Kim McCleary

Online presence

• PubMed
• LinkedIn

Learn more

• Pain & Fatigue Study Center Homepage

See also

• Benjamin Natelson

central nervous system (CNS) - One of the two parts of the human nervous system, the other part being the peripheral nervous system. The central nervous system consists of the brain and spinal cord, while the peripheral nervous system consists of nerves that travel from the central nervous system into the various organs and tissues of the body.

cognition Thought processes, including attention, reasoning, and memory.

cognition Thought processes, including attention, reasoning, and memory.

phase one A drug trial involving only a small group of humans, often healthy volunteers, to assess drug safety and side effects. Typically 20-80 participants, often using a comparison group.

See myalgic encephalomyelitis.

See chronic fatigue syndrome.

See National Institutes of Health.

National Institutes of Health (NIH) - A set of biomedical research institutes operated by the U.S. government, under the auspices of the Department of Health and Human Services.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.